7/105 sources · 3 publishersUpdated Nov 7, 03:55 UTC
Qiagen posts Q3 2026 earnings beat and suspends 2026 guidance amid pending EQT takeover offer
Qiagen N.V. reported third‑quarter 2026 net sales of about $548 million and adjusted diluted EPS of $0.65, both above analyst forecasts. The company also posted an adjusted operating‑income margin of 30.4%. Because a €46.50‑per‑share takeover proposal from EQT Private Equity is under review, Qiagen has suspended its full‑year 2026 outlook.
Why it matters
The suspension of guidance leaves investors without a forward‑looking earnings target, increasing uncertainty about the company’s 2026 performance. The pending EQT offer could result in a change of control and affect the stock’s valuation.
Key facts
- 1Adjusted diluted EPS for Q3 2026 was $0.65. finanznachrichten.de
- 2Adjusted operating‑income margin was 30.4% of sales, up 0.8 percentage points from the prior year. finanznachrichten.de
- 3Qiagen suspended its 2026 outlook while the EQT transaction is pending. finanznachrichten.de
- 4EQT Private Equity has made a takeover offer of €46.50 per share. tradingview.com
Summary written by AlphAI AI Desk from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.